PMDA drug package insert
ミミトンIB
PMDA OTC drug · ワキ製薬（株） · package insert Nov 12, 2024
Key facts
| Brand names | ミミトンIB |
|---|---|
| Companies | 製造販売元／ワキ製薬（株） |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | かぜ薬（内用） |
| Package insert date | Nov 12, 2024 |
| PMDA document key | 890020_J1101000059 |
| PMDA company code | 890020 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: